FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2327839999> ?p ?o ?g. }

• W2327839999 endingPage "A808" @default.
• W2327839999 startingPage "A808.1" @default.
• W2327839999 abstract "<h3>Background</h3> There is increasing evidence that synovial activation contributes to osteoarthritis (OA) pathology and that it is present in a large subset of OA patients. Previously, we found that alarmins S100A8 and S100A9 are elevated in the synovium of OA patients and that high S100A8/A9 serum levels correlate with 2-year progression of the disease. Furthermore, these S100-proteins are involved in cartilage degradation and synovial activation in experimental OA. Paquinimod is a quinoline-3-carboxamide compound with immunomodulatory properties that is currently in clinical development for treatment of systemic sclerosis. It targets the S100A9 protein and disrupts the binding of S100A9 to RAGE and TLR-4. <h3>Objectives</h3> In the current study we investigated the effect of the S100A9-blocking compound paquinimod on experimental osteoarthritis with different degrees of synovial involvement. <h3>Methods</h3> Collagenase induced OA (CIOA) was induced by two times intra-articular injection of 1U collagenase and DMM was induced by transsection of the medial anterior meniscotibial ligament leading to destabilization of the medial meniscus (DMM), both in C57Bl6 mice. CIOA measurements were done at day 42, DMM at day 56. Paquinimod (71,5 μM) was administered in the drinking water 4 days before induction of OA in both CIOA and DMM and refreshed twice a week. Synovial thickening and cellularity was measured using an arbitrary score from 0-3. OA-like cartilage pathology was scored using a modified Pritzker OARSI score. Osteophyte size was assessed by a blinded observer using imaging software. <h3>Results</h3> We assessed the effect of paquinimod-treatment on two different experimental OA models. In CIOA, synovial activation is high throughout day 42 of the model, whereas during DMM synovial activation is marginal. We started with paquinimod-treatment of DMM mice and focused first on osteophytes. These are bony outgrowths that limit joint formation, originating from the periosteum or from ligaments. No differences were observed on osteophyte size between paquinimod-treated and non-treated animals at both medial tibia and medial femur. Furthermore, OA-like cartilage pathology was only significantly reduced by paquinimod-treatment at the medial femur (64%), not at other surfaces and not in the total joint score (16%). Next, we investigated the effect of paquinimod-treatment in an OA model with synovial activation. In CIOA, synovial activation was significantly reduced by paquinimod-treatment at the medial side of the patella-femur region (57%). Osteophyte size was significantly reduced at the medial femur (66%) and cruciate ligaments (67%). Finally, OA-like cartilage pathology was significantly reduced in CIOA after paquinimod treatment on the medial side of both tibia and femur (47% and 75% respectively) as well as in the total joint score (46%). <h3>Conclusions</h3> Blocking S100A9 with paquinimod reduces synovial activation, osteophyte formation and OA-like cartilage pathology in CIOA. In contrast, in an experimental OA model where synovial activation is nearly absent (DMM), the effect of paquinimod is marginal. Paquinimod could prove a very promising treatment for osteoarthritis patients with high synovial activation by blocking S100A9. <h3>Disclosure of Interest</h3> None Declared" @default.
• W2327839999 created "2016-06-24" @default.
• W2327839999 creator A5022616402 @default.
• W2327839999 creator A5033535335 @default.
• W2327839999 creator A5058446721 @default.
• W2327839999 creator A5062350357 @default.
• W2327839999 creator A5082338147 @default.
• W2327839999 creator A5086554744 @default.
• W2327839999 date "2013-06-01" @default.
• W2327839999 modified "2023-09-27" @default.
• W2327839999 title "AB0073 The s100a9 inhibitor paquinimod (abr-215757) ameliorates experimental osteoarthritis with high synovial involvement" @default.
• W2327839999 doi "https://doi.org/10.1136/annrheumdis-2013-eular.2396" @default.
• W2327839999 hasPublicationYear "2013" @default.
• W2327839999 type Work @default.
• W2327839999 sameAs 2327839999 @default.
• W2327839999 citedByCount "0" @default.
• W2327839999 crossrefType "journal-article" @default.
• W2327839999 hasAuthorship W2327839999A5022616402 @default.
• W2327839999 hasAuthorship W2327839999A5033535335 @default.
• W2327839999 hasAuthorship W2327839999A5058446721 @default.
• W2327839999 hasAuthorship W2327839999A5062350357 @default.
• W2327839999 hasAuthorship W2327839999A5082338147 @default.
• W2327839999 hasAuthorship W2327839999A5086554744 @default.
• W2327839999 hasConcept C105702510 @default.
• W2327839999 hasConcept C126322002 @default.
• W2327839999 hasConcept C142724271 @default.
• W2327839999 hasConcept C181199279 @default.
• W2327839999 hasConcept C185592680 @default.
• W2327839999 hasConcept C204787440 @default.
• W2327839999 hasConcept C2776164576 @default.
• W2327839999 hasConcept C2776307749 @default.
• W2327839999 hasConcept C2776914184 @default.
• W2327839999 hasConcept C2777077863 @default.
• W2327839999 hasConcept C2777652487 @default.
• W2327839999 hasConcept C2778394429 @default.
• W2327839999 hasConcept C2778557267 @default.
• W2327839999 hasConcept C2779244835 @default.
• W2327839999 hasConcept C2780550940 @default.
• W2327839999 hasConcept C55493867 @default.
• W2327839999 hasConcept C71924100 @default.
• W2327839999 hasConceptScore W2327839999C105702510 @default.
• W2327839999 hasConceptScore W2327839999C126322002 @default.
• W2327839999 hasConceptScore W2327839999C142724271 @default.
• W2327839999 hasConceptScore W2327839999C181199279 @default.
• W2327839999 hasConceptScore W2327839999C185592680 @default.
• W2327839999 hasConceptScore W2327839999C204787440 @default.
• W2327839999 hasConceptScore W2327839999C2776164576 @default.
• W2327839999 hasConceptScore W2327839999C2776307749 @default.
• W2327839999 hasConceptScore W2327839999C2776914184 @default.
• W2327839999 hasConceptScore W2327839999C2777077863 @default.
• W2327839999 hasConceptScore W2327839999C2777652487 @default.
• W2327839999 hasConceptScore W2327839999C2778394429 @default.
• W2327839999 hasConceptScore W2327839999C2778557267 @default.
• W2327839999 hasConceptScore W2327839999C2779244835 @default.
• W2327839999 hasConceptScore W2327839999C2780550940 @default.
• W2327839999 hasConceptScore W2327839999C55493867 @default.
• W2327839999 hasConceptScore W2327839999C71924100 @default.
• W2327839999 hasIssue "Suppl 3" @default.
• W2327839999 hasLocation W23278399991 @default.
• W2327839999 hasOpenAccess W2327839999 @default.
• W2327839999 hasPrimaryLocation W23278399991 @default.
• W2327839999 hasRelatedWork W1977929761 @default.
• W2327839999 hasRelatedWork W2010899655 @default.
• W2327839999 hasRelatedWork W2063391683 @default.
• W2327839999 hasRelatedWork W2147100304 @default.
• W2327839999 hasRelatedWork W2222663982 @default.
• W2327839999 hasRelatedWork W2327839999 @default.
• W2327839999 hasRelatedWork W2357048355 @default.
• W2327839999 hasRelatedWork W2556796503 @default.
• W2327839999 hasRelatedWork W2797345399 @default.
• W2327839999 hasRelatedWork W3031203826 @default.
• W2327839999 hasVolume "72" @default.
• W2327839999 isParatext "false" @default.
• W2327839999 isRetracted "false" @default.
• W2327839999 magId "2327839999" @default.
• W2327839999 workType "article" @default.